Cationic ligand appended nanoconstructs: A prospective strategy for brain targeting

International Journal of Pharmaceutics

Volumn 421, Issue 1, 2011, Pages 189-201

  Agarwal, Abhinav ^a   Agrawal, Himanshu ^b   Tiwari, Shailja ^a   Jain, Sanyog ^c   Agrawal, Govind P ^a  

^a DR H S GOUR UNIVERSITY   (India)

^b M S UNIVERSITY OF BARODA   (India)

^c NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Blood brain barrier; Cationic bovine serum albumin; Doxorubicin; Solid lipid nanoparticles; Transcytosis

Indexed keywords

BOVINE SERUM ALBUMIN; CATIONIC BOVINE SERUM ALBUMIN; DOXORUBICIN; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY; CAPILLARY ENDOTHELIUM; COMPLEX FORMATION; CONJUGATION; CONTROLLED STUDY; CYTOTOXICITY; DISPERSION; DRUG DELIVERY SYSTEM; DRUG UPTAKE; FEMALE; IN VIVO STUDY; INFRARED SPECTROSCOPY; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE SIZE; PRIORITY JOURNAL; SYNTHESIS; TRANSCYTOSIS; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ASTROCYTES; CATIONS; CELL LINE; CELLS, CULTURED; DOXORUBICIN; DRUG CARRIERS; ENDOTHELIAL CELLS; HUMANS; KIDNEY; LIGANDS; LIPIDS; LIVER; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PARTICLE SIZE; SERUM ALBUMIN, BOVINE; TISSUE DISTRIBUTION;

EID: 81155128611     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.09.039     Document Type: Article

References (43)

1. A. Agarwal, A. Asthana, U. Gupta, and N.K. Jain Tumour and dendrimers: a review on drug delivery aspects J. Pharm. Pharmacol. 60 2008 671 688 (Pubitemid 351702440)
2. A. Agarwal, U. Gupta, A. Asthana, and N.K. Jain Dextran conjugated dendritic nanoconstructs as potential vectors for anti-cancer agent Biomaterials 30 2009 3588 3596
3. A. Agarwal, N. Lariya, G.K. Saraogi, N. Dubey, H. Agrawal, and G.P. Agrawal Nanoparticles as novel carrier for brain delivery: a review Curr. Pharm. Des. 15 2009 917 925
4. T.A. Ajith, M.S. Aswathy, and U. Hema Protective effect of Zingiber officinale Roscoe against anticancer drug doxorubicin-induced acute nephrotoxicity Food Chem. Toxicol. 46 2008 3178 3181
5. D. Begley, H.S. Sharma, and J. Westman Blood, Spinal Cord and Brain Barriers in Health and Disease 2003 Elsevier Sci. USA pp. 83-97
6. D.J. Begley, and M.W. Brightman Structural and functional aspects of the blood-brain barrier Prog. Drug Res. 61 2003 39 78 (Pubitemid 37187402)
7. D. Bhadra, A.K. Yadav, S. Bhadra, and N.K. Jain Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting Int. J. Pharm. 295 2005 221 233 (Pubitemid 40558805)
8. U. Bickel, T. Yoshikawa, and W.M. Pardridge Delivery of peptides and proteins through the blood-brain barrier Adv. Drug Deliv. Rev. 46 2001 247 279
9. I. Brigger, J. Morizet, L. Laudani, G. Aubert, M. Appel, and V. Velasco Negative preclinical results with stealth nanospheres-encapsulated doxorubicin in an orthopic murine brain tumor model J. Control. Release 100 2004 29 40 (Pubitemid 39445983)
10. R. Cavalli, O. Caputo, M.E. Carlotti, M. Trotta, C. Scarnecchia, and M.R. Gasco Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles Int. J. Pharm. 148 1997 47 54 (Pubitemid 27152216)
11. Y. Feng, Y. Zhou, Q. Zou, J. Wang, F. Chen, and Z. Gao Preparation and characterization of bisphenol A-cationized bovine serum albumin J. Immunol. Methods 340 2009 138 143
12. A.E. Gulyaev, S.E. Gelperina, I.N. Skidan, A.S. Antropov, G.Y. Kivman, and J. Kreuter Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles Pharm. Res. 16 1999 1564 1569 (Pubitemid 29510553)
13. M. Huang, Z. Ma, E. Khor, and L.Y. Lim Uptake of FITC-chitosan nanoparticles by A549 cells Pharm. Res. 19 2002 1488 1494 (Pubitemid 35266553)
14. 24 in doxorubicin-induced hepatotoxicity in rats with mammary carcinomas Biomaterials 29 2008 3451 3460
15. A. Jain, A. Agarwal, S. Majumder, N. Lariya, A. Khaya, and H. Agrawal Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anticancer drug J. Control. Release 3 2010 359 367
16. L. Juillerat-Jeanneret The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles Drug Discov. Today 13 2008 1099 1106
17. P. Kolhe, E. Misra, R.M. Kannan, S. Kannan, and M. Lieh- Lai Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers Int. J. Pharm. 259 2003 143 160 (Pubitemid 36638561)
18. W. Lu, Q. Sun, J. Wan, Z. She, and X.G. Jiang Cationic albumin conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration Cancer Res. 66 2006 11878 11887 (Pubitemid 46094200)
19. W. Lu, Y.Z. Tan, K.L. Hu, and X.G. Jiang Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier Int. J. Pharm. 295 2005 247 260 (Pubitemid 40558807)
20. B. Magenheim, M.Y. Levy, and S. Benita A new in vitro technique for evaluation of drug release profile from colloidal carriers-ultrafiltration technique at low pressure Int. J. Pharm. 94 1993 115 123 (Pubitemid 23204057)
21. Martindale The Extra Pharmacopoeia 31st ed. 1996 Royal Pharmaceutical Society London, Pharmaceutical Press London p. 567
22. S.M. Moghimi, A.C. Hunter, and J.C. Murray Nanomedicine: current status and future prospects FASEB J. 19 2005 311 330 (Pubitemid 40316520)
23. R.H. Muller, D. Ruhl, S. Runge, K. Schulze-Foster, and W. Mehnert Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant Pharm. Res. 4 1997 458 462 (Pubitemid 27205004)
24. W.M. Pardridge Blood-brain barrier drug targeting: the future of brain drug development Mol. Interv. 3 2003 90 105
25. K. Park, G.Y. Lee, Y.S. Kim, M. Yu, R.W. Park, and I.S. Kim Heparin-deoxycholic acid chemical conjugate as an anticancer drug carrier and its antitumor activity J. Control. Release 114 2006 300 306 (Pubitemid 44310810)
26. Y. Persidsky, S.H. Ramirez, J. Haorah, and G.D. Kanmogne Blood-brain barrier: structural components and function under physiologic and pathologic conditions J. Neuroimmunol. Pharm. 1 2006 223 236 (Pubitemid 44244128)
27. B. Petri, A. Bootz, A. Khalansky, T. Hekmatara, R. Muller, and R. Uhl Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants J. Control. Release 117 2007 51 58 (Pubitemid 46164866)
28. L.H. Reddy, R.K. Sharma, K. Chuttani, A.K. Mishra, and R.R. Murthy Etoposide-incorporated tripalmitin nanoparticles with different surface charge: formulation, characterization, radiolabeling and biodistribution studies AAPS J. 6 2004 1 10
29. A.H. Schinkel P-glycoprotein, a gatekeeper in the blood-brain barrier Adv. Drug Deliv. Rev. 36 1999 179 194 (Pubitemid 29121971)
30. M.A. Schubert, and C.C. Muller-Goymann Solvent injection as a new approach for manufacturing lipid nanoparticles - evaluation of the method and process parameters Eur. J. Pharm. Biopharm. 55 2003 125 131 (Pubitemid 36120504)
31. C. Schwarz, and W. Mehnert Solid lipid nanoparticles (SLN) for controlled drug delivery. II. Drug incorporation and physicochemical characterization J. Microencapsul. 16 1999 205 213 (Pubitemid 29099602)
32. V. Soni, D.V. Kohli, and S.K. Jain Transferrin coupled liposomes for enhanced brain delivery of doxorubicin Vasc. Dis. Prev. 3 2006 31 38
33. P.B. Storm, J.L. Moriarity, B. Tyler, P.C. Burger, H. Brem, and J. Weingart Polymer delivery of camptothecin against 9L gliosarcoma: release, distribution, and efficacy J. Neurooncol. 56 2002 209 217 (Pubitemid 34476989)
34. M. Thole, S. Nobmanna, J. Huwyler, A. Bartmann, and G. Fricker Uptake of cationized albumin coupled liposomes by cultured porcine brain microvessel endothelial cells and intact brain capillaries J. Drug Target. 103 2002 37 44
35. V.P. Torchilin Recent advances with liposomes as pharmaceutical carriers Nat. Rev. Drug Discov. 41 2005 45 60
36. S. Utreja, and N.K. Jain Solid lipid nanoparticles N.K. Jain, Advances in Controlled and Novel Drug Delivery 2001 CBS Publishers New Delhi pp. 408-425
37. S.P. Vyas, and R.K. Khar Targeted and Controlled Drug Delivery Novel Carrier Systems 1st ed. 2002 CBS Publishers New Delhi pp. 331-86
38. K.J. Wiechelman, R.D. Braun, and J.D. Fitzpatrick BCA assay protocol Anal. Biochem. 1988 175
39. H.L. Wong, R. Bendayan, A.M. Rauth, H.Y. Xue, K. Babakhanian, and X.Y. Wu A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system J. Pharmacol. Exp. Ther. 317 2006 1372 1381 (Pubitemid 43764144)
40. D. Wu, and W.M. Pardridge Blood-brain barrier transport of reduced folic acid Pharm. Res. 16 1999 415 419 (Pubitemid 29162100)
41. Y.L. Xie, W. Lu, and X.G. Jiang Improvement of cationic albumin conjugated pegylated nanoparticles holding NC-1900, a vasopressin fragment analog, in memory deficits induced by scopolamine in mice Behav. Brain. Res. 173 2006 76 84 (Pubitemid 44572015)
42. A.K. Yadav, P. Mishra, A.K. Mishra, P. Mishra, S. Jain, and G.P. Agrawal Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin Nanomed. Nanotechnol. Biol. Med. 3 2007 246 257 (Pubitemid 350199644)
43. A.K. Yadav, A. Agarwal, S. Jain, A.K. Mishra, H. Bid, and G. Rai Chondroitin sulphate decorated nanoparticulate carriers of 5-fluorouracil: development and in vitro characterization J. Biomed. Nanotechnol. 6 2010 1 11